MDGL
MDGL
View Detailed Chart
438.900USD
-3.230-0.73%
Close 10/17, 16:00（ET）Quotes delayed by 15 min
9.75BMarket Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.73%
5 Days
+2.16%
1 Month
-0.42%
6 Months
+45.49%
Year to Date
+42.24%
1 Year
+104.67%
View Detailed Chart
TradingKey Stock Score of MDGL
Currency: USD Updated: 2025-10-17Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
MDGL's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
16
analysts
Buy
Current Rating
415.786
Target Price
+25.53%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
MDGL Highlights
StrengthsRisks
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 180.13M.
Undervalued
The company’s latest PE is -34.70, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.95M shares, decreasing 9.11% quarter-over-quarter.
Held by John Paulson
Star Investor John Paulson holds 2.09M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
MDGL Info
Ticker SymbolMDGL
CompanyMadrigal Pharmaceuticals Inc
CEOMr. Bill Sibold
Websitehttps://www.madrigalpharma.com/
Related Instruments
+0.76%
-6.83%
+1.57%
-0.58%
-0.50%
+0.06%
-4.46%
-3.56%
+1.32%
-1.80%
+1.68%
+0.03%
-0.10%
+0.10%
+0.31%
+8.90%
+0.42%
+1.57%
+1.95%
-3.01%Popular Symbols
